NasdaqGS - Nasdaq Real Time Price USD
Spyre Therapeutics, Inc. (SYRE)
14.10
+1.24
+(9.64%)
At close: May 9 at 4:00:00 PM EDT
14.10
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
608,484
341,859
71,144
109,926
Total Liabilities Net Minority Interest
90,680
157,843
20,839
25,985
Total Equity Gross Minority Interest
517,804
184,016
50,305
83,941
Total Capitalization
517,804
184,016
50,305
83,941
Preferred Stock Equity
155,820
184,927
--
--
Common Stock Equity
361,984
-911
50,305
83,941
Capital Lease Obligations
--
0
4,629
5,060
Net Tangible Assets
517,804
184,016
50,305
83,941
Working Capital
554,414
309,550
47,602
78,747
Invested Capital
361,984
-911
50,305
83,941
Tangible Book Value
361,984
-911
50,305
83,941
Total Debt
--
0
4,629
5,060
Share Issued
60,257.02
36,057.11
2,614.01
1,974.21
Ordinary Shares Number
60,257.02
36,057.11
2,614.01
1,974.21
Treasury Shares Number
--
0
--
--
12/31/2021 - 4/7/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APGE Apogee Therapeutics, Inc.
37.29
-1.38%
DNTH Dianthus Therapeutics, Inc.
19.59
-5.00%
ABVX ABIVAX Société Anonyme
6.71
-2.04%
XNCR Xencor, Inc.
8.33
-5.23%
ORKA Oruka Therapeutics, Inc.
9.54
-2.15%
TRML Tourmaline Bio, Inc.
15.10
-4.07%
VRDN Viridian Therapeutics, Inc.
12.39
-3.05%
IRON Disc Medicine, Inc.
44.24
-0.11%
ELVN Enliven Therapeutics, Inc.
18.42
-1.13%
NAMS NewAmsterdam Pharma Company N.V.
18.37
-4.67%